AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENETIC SIGNATURES LTD

0.083

+0.0033.75%

Volume:1.19M

Turnover:99.08K

Market Cap:18.85M

PE:-1.69

High:0.085

Open:0.083

Low:0.081

Close:0.080

52wk High:0.430

52wk Low:0.051

Shares:227.14M

Float Shares:188.02M

Volume Ratio:1.71

T/O Rate:0.63%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.049

EPS(LYR):-0.089

ROE:-32.64%

ROA:-15.95%

PB:0.53

PE(LYR):-0.94

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment+0.66%

Capital Flow

Inflow:

Outflow:

News

Australia's Genetic Signatures Climbs on Potential Merger with Microba

Genetic Signatures - Combined Group to Benefit from Streamlined Cost Base and Potential Accelerated Growth

THOMSON REUTERS

Genetic Signatures Ltd - FY Revenues from Ordinary Activities A$14.8 Mln

THOMSON REUTERS

Genetic Signatures Ltd-Commercial Testing Commences at Hvidovre Hospital in Denmark

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://nz.tigermarketb.com/stock/GSS.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.083,"timestamp":1787724720000,"preClose":0.08,"halted":0,"volume":1190562,"delay":0,"changeRate":0.03750000000000003,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.049055,"marketStatus":"Not Yet Opened","change":0.003,"latestTime":"08-26 16:12:00 AEST","open":0.083,"high":0.085,"low":0.081,"amount":99079,"amplitude":0.05,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.049055,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.08,"openAndCloseTimeList":[[1787702400000,1787724000000]],"volumeRatio":1.712507109303327,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.08,"auctionPrice":0.083,"auctionVolume":215665,"auction":3,"marketStatus":"盘后竞价","timestamp":1787724586778}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-15.95%","roe":"-32.64%","lyrEps":-0.088679,"volumeRatio":1.712507109303327,"shares":227138828,"dividePrice":0,"high":0.085,"amplitude":0.05,"preClose":0.08,"low":0.081,"week52Low":0.051,"pbRate":"0.53","psRate":"0.93","week52High":0.43,"institutionHeld":0,"latestPrice":0.083,"eps":-0.049055,"divideRate":0,"volume":1190562,"delay":0,"ttmEps":-0.049055,"open":0.083,"prevYearClose":0.25,"prevWeekClose":0.068,"prevMonthClose":0.059,"prevQuarterClose":0.067,"fiveDayClose":0.059,"twentyDayClose":0.058,"sixtyDayClose":0.069,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662767137","title":"Australia's Genetic Signatures Climbs on Potential Merger with Microba","url":"https://stock-news.laohu8.com/highlight/detail?id=2662767137","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662767137?lang=en_us&edition=fundamental","pubTime":"2026-08-26 13:40","pubTimestamp":1787722801,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Genetic Signatures climbs on potential merger with Microba** Shares of Australia's Genetic SignaturesGSS.AXrise as much as 6.9% to A$0.0855, hitting their highest level since May 4** ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nL4N44N0AX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","MAP.AU","BK7048","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662476825","title":"Genetic Signatures - Combined Group to Benefit from Streamlined Cost Base and Potential Accelerated Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662476825","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662476825?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:30","pubTimestamp":1787700640,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nTUENDSZ2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7124","BK7048","BK7501","GSS.AU","MAP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662048712","title":"Genetic Signatures Ltd - FY Revenues from Ordinary Activities A$14.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662048712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662048712?lang=en_us&edition=fundamental","pubTime":"2026-08-25 07:15","pubTimestamp":1787613347,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0UW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258927","title":"Genetic Signatures Ltd-Commercial Testing Commences at Hvidovre Hospital in Denmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258927?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:26","pubTimestamp":1787268401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUE50GHHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7501","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GSS.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.006551}]}}